Merck & Co., Inc.
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$149.52+3.19 (+2.18%)
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Operating Lease Liabilities — Total by Year
Operating Lease Liabilities — Total ($M) ($M)
Merck Operating Lease Liabilities — Total: $1,195M in FY2025, up 3.1% from a year earlier.
Latest, FY2025
1,195
Period ended Dec 31, 2025
Change on a year earlier
+3.1%
1,159 in FY2024
History
7 years
Since FY2019
Sources
6
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-24) ↗
Reported in Form 10-K Note 10 Leases.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Operating Lease Liabilities — Total ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,195 | +3.1% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 1,159 | -4.5% | Form 10-K (filed 2026-02-24) ↗ |
| FY2023 | Dec 31, 2023 | 1,213 | -6.3% | Form 10-K (filed 2025-02-25) ↗ |
| FY2022 | Dec 31, 2022 | 1,294 | -15.4% | Form 10-K (filed 2024-02-26) ↗ |
| FY2021 | Dec 31, 2021 | 1,529 | -6.0% | Form 10-K (filed 2023-02-24) ↗ |
| FY2020 | Dec 31, 2020 | 1,626 | +62.0% | Form 10-K (filed 2022-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 1,004 | – | Form 10-K (filed 2021-02-25) ↗ |
Cite this data
StockData. (2026). Merck Operating Lease Liabilities — Total ($M), annual FY2019–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/lease-liab-tot
See every metric in the Merck KPI table. Data updated Oct 26, 2026.